Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | UBQLN4 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of UBQLN4 mRNA | CTD | PMID:22079256 | UBQLN4 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Ubqln4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of UBQLN4 mRNA | CTD | PMID:22206623 | UBQLN4 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Ubqln4 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of UBQLN4 mRNA | CTD | PMID:17555576 | UBQLN4 | Human | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of UBQLN4 mRNA | CTD | PMID:22574217 | UBQLN4 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of UBQLN4 mRNA | CTD | PMID:23019147 | UBQLN4 | Human | 2,4-dinitrotoluene | affects expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of UBQLN4 mRNA | CTD | PMID:21346803 | UBQLN4 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Ubqln4 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of UBQLN4 exon | CTD | PMID:33297965 | UBQLN4 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Ubqln4 (Mus musculus) | 6480464 | bisphenol S affects the methylation of UBQLN4 gene | CTD | PMID:31683443 | UBQLN4 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of UBQLN4 mRNA | CTD | PMID:21346803 | UBQLN4 | Human | actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of UBQLN4 protein | CTD | PMID:38460933 | UBQLN4 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of UBQLN4 intron | CTD | PMID:30157460 | UBQLN4 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of UBQLN4 mRNA | CTD | PMID:33212167 | UBQLN4 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of UBQLN4 gene | CTD | PMID:25304211 | UBQLN4 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of UBQLN4 gene | CTD | PMID:25304211 | UBQLN4 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of UBQLN4 mRNA | CTD | PMID:38218311 | UBQLN4 | Human | bisphenol A | decreases expression | ISO | Ubqln4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of UBQLN4 mRNA | CTD | PMID:26063408 | UBQLN4 | Human | bisphenol A | decreases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of UBQLN4 mRNA | CTD | PMID:34947998 | UBQLN4 | Human | bisphenol A | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of UBQLN4 mRNA | CTD | PMID:25181051 | UBQLN4 | Human | C60 fullerene | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of UBQLN4 mRNA | CTD | PMID:19167457 | UBQLN4 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of UBQLN4 protein | CTD | PMID:35688186 | UBQLN4 | Human | copper atom | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | Copper results in increased expression of UBQLN4 mRNA | CTD | PMID:30556269 | UBQLN4 | Human | copper(0) | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | Copper results in increased expression of UBQLN4 mRNA | CTD | PMID:30556269 | UBQLN4 | Human | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of UBQLN4 protein | CTD | PMID:34122009 | UBQLN4 | Human | cyclosporin A | decreases methylation | EXP | | 6480464 | Cyclosporine results in decreased methylation of UBQLN4 promoter | CTD | PMID:27989131 | UBQLN4 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of UBQLN4 mRNA | CTD | PMID:37042841 | UBQLN4 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of UBQLN4 mRNA | CTD | PMID:28302478 | UBQLN4 | Human | endosulfan | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of UBQLN4 mRNA | CTD | PMID:31464424 | UBQLN4 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UBQLN4 protein | CTD | PMID:23301498 | UBQLN4 | Human | ethanol | affects splicing | ISO | Ubqln4 (Mus musculus) | 6480464 | Ethanol affects the splicing of UBQLN4 mRNA | CTD | PMID:30319688 | UBQLN4 | Human | flutamide | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of UBQLN4 mRNA | CTD | PMID:24136188 | UBQLN4 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of UBQLN4 mRNA | CTD | PMID:23649840 | UBQLN4 | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of UBQLN4 mRNA | CTD | PMID:23019147 | UBQLN4 | Human | haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of UBQLN4 protein | CTD | PMID:34122009 | UBQLN4 | Human | hydrogen peroxide | multiple interactions | ISO | Ubqln4 (Mus musculus) | 6480464 | N-(oxo-5 more ... | CTD | PMID:31494107 | UBQLN4 | Human | hydrogen peroxide | increases phosphorylation | ISO | Ubqln4 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased phosphorylation of UBQLN4 protein | CTD | PMID:31494107 | UBQLN4 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of UBQLN4 protein | CTD | PMID:32959892 | UBQLN4 | Human | Nutlin-3 | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of UBQLN4 protein | CTD | PMID:38460933 | UBQLN4 | Human | paracetamol | decreases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of UBQLN4 mRNA | CTD | PMID:33387578 | UBQLN4 | Human | phenobarbital | affects expression | ISO | Ubqln4 (Mus musculus) | 6480464 | Phenobarbital affects the expression of UBQLN4 mRNA | CTD | PMID:23091169 | UBQLN4 | Human | pirinixic acid | increases expression | ISO | Ubqln4 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of UBQLN4 mRNA | CTD | PMID:18301758 | UBQLN4 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of UBQLN4 mRNA | CTD | PMID:22079256 | UBQLN4 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of UBQLN4 mRNA | CTD | PMID:22079256 | UBQLN4 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of UBQLN4 mRNA | CTD | PMID:23557933 | UBQLN4 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of UBQLN4 protein | CTD | PMID:37664457 | UBQLN4 | Human | sevoflurane | increases methylation | ISO | Ubqln4 (Mus musculus) | 6480464 | Sevoflurane results in increased methylation of UBQLN4 mRNA | CTD | PMID:35249202 | UBQLN4 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of UBQLN4 mRNA | CTD | PMID:38568856 | UBQLN4 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of UBQLN4 mRNA | CTD | PMID:31533062 | UBQLN4 | Human | tamoxifen | affects expression | ISO | Ubqln4 (Mus musculus) | 6480464 | Tamoxifen affects the expression of UBQLN4 mRNA | CTD | PMID:17555576 | UBQLN4 | Human | tetrachloromethane | increases expression | ISO | Ubqln4 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of UBQLN4 mRNA | CTD | PMID:31919559 | UBQLN4 | Human | thioacetamide | increases expression | ISO | Ubqln4 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of UBQLN4 mRNA | CTD | PMID:34492290 | UBQLN4 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of UBQLN4 mRNA | CTD | PMID:38568856 | UBQLN4 | Human | titanium dioxide | increases methylation | ISO | Ubqln4 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of UBQLN4 gene | CTD | PMID:35295148 | UBQLN4 | Human | triptonide | increases expression | ISO | Ubqln4 (Mus musculus) | 6480464 | triptonide results in increased expression of UBQLN4 mRNA | CTD | PMID:33045310 | |